Medpace (MEDP)
(Delayed Data from NSDQ)
$423.09 USD
-4.11 (-0.96%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $423.39 +0.30 (0.07%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth B Momentum B VGM
Fundamental Charts
About Dividend Yield (TTM)
Medpace Holdings, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical Services industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
MEDP 423.09 -4.11(-0.96%)
Will MEDP be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for MEDP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MEDP
TMDX Stock Gains Post Q2 Earnings & Revenue Beat, Margins Up
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
MEDP: What are Zacks experts saying now?
Zacks Private Portfolio Services
GKOS Stock Falls Despite Q2 Earnings & Revenues Beat, Guidance Raised
CONMED Q2 Earnings & Revenues Beat Estimates, 2025 Outlook Raised
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
Other News for MEDP
Sarepta upgraded, Tapestry downgraded: Wall Street's top analyst calls
Uber To Rally Around 29%? Here Are 10 Top Analyst Forecasts For Tuesday
MEDP: UBS Downgrades Medpace Holdings, Raises Price Target | MEDP Stock News
Medpace just downgraded at UBS, here's why
UBS Downgrades Medpace (MEDP) Citing Overambitious Targets